Targeted Oncology brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.
…
continue reading
Rhode Islands best and largest indoor airsoft pro-shop and gaming arena! Join us for our weekly podcasts, live 5-630pm!
…
continue reading
Target is an award-winning UK communications agency that has been helping clients to achieve their goals through purposeful and clear communications, for more than 45 years. The first series of Target Talks, hosted by Target’s Chief Executive, Sarah Bryars, and Director, Sam Kandiyali, explores the value of purpose-led communications and how businesses can deliver purposeful PR. With more and more organisations thinking about their purpose and how they enact it, in 2022 Target launched the P ...
…
continue reading
In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting.Από τον Targeted Talks
…
continue reading
In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.Από τον Targeted Talks
…
continue reading
In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment a…
…
continue reading
In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.Από τον Targeted Talks
…
continue reading
In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.Από τον Targeted Talks
…
continue reading
In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy.Από τον Targeted Talks
…
continue reading
In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.Από τον Targeted Talks
…
continue reading
In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.Από τον Targeted Talks
…
continue reading
In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.…
…
continue reading
In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.…
…
continue reading
In this episode of Target Talks, Sarah Bryars sits down with Adrian Jones, Group Head of PR at the Benefact Group to discuss the role of PR in delivering their organisation’s purpose. Adrian begins by introducing listeners to the unique set-up of the Benefact Group and how it has evolved since its beginnings 135 years ago, to insure some of today’s…
…
continue reading
In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities.Από τον Targeted Talks
…
continue reading
In this episode of Target Talks, Sam Kandiyali is joined by Josephine Osborne, Senior Project Manager at Specsavers. Jo begins by talking about Specsavers’ work in improving lives through better sight and hearing – the organisation’s purpose. She introduces listeners to Specsavers Homelessness programme which focuses on making eye and hearing care …
…
continue reading
In this episode of Target Talks, Sarah Bryars and Sam Kandiyali are joined by Spencer McPherson, Chief Creative Officer of Still Moving, a creative agency who produce dynamic and engaging photography and film for brands around the world. Spencer begins (and ends) this episode by sharing stories of some of the many famous faces he has photographed, …
…
continue reading
In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.Από τον Targeted Talks
…
continue reading
On this episode of Target Talks, Sarah Bryars is joined by Simone Hindmarch, Co-founder and Managing Director of Commercial. Simone begins by telling us how, back in 2006, an invite to a client’s screening of An Inconvenient Truth became an ‘epiphany moment’ for her and kickstarted Commercial’s sustainability journey. Sarah and Simone discuss the i…
…
continue reading
On this episode of Target Talks, Sarah Bryars and Sam Kandiyali sit down with Luan Wise, social media consultant and founder of The Lighthouse. As Luan tells us, she wasn’t one of social media’s first adopters– in fact, she was adamant that it wouldn’t take off... but that was back in 2007. She shares how she made the leap from account manager at a…
…
continue reading
In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.…
…
continue reading
On the first episode of Target Talks, Sam Kandiyali is joined by Frank Nigriello, Director of Corporate Affairs at Unipart Group. Frank begins by sharing what purpose means to him in his role at Unipart, and the part that purpose plays in decision-making. Sam and Frank chat about the Pillars of Purpose model, and how PR can help businesses to build…
…
continue reading
If you’re thinking about how you and your organisation can be a force for good, this podcast is a must listen. The six-episode series, brought to you by Target, an award-winning UK communications agency, explores different aspects of purposeful PR and communications. From building communities, to storytelling, engaging stakeholders and influencing …
…
continue reading
In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.Από τον Targeted Talks
…
continue reading
In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.Από τον Targeted Talks
…
continue reading
Alicia Morgan, MD, MPH on real-world data from the DEAR study.Από τον Targeted Talks
…
continue reading
An interview with Benny Weskler, MBA, MD, FACS, FACCP of Allegheny Health Network.Από τον Targeted Talks
…
continue reading
Federico Albrecht, MD discusses 2 small cell lung cancer cases.Από τον Targeted Talks
…
continue reading
Από τον Targeted Talks
…
continue reading
Craig Horbinski, MD, PhD, unpacks the NCCN Clinical Practice Guidelines for central nervous system tumors.Από τον Targeted Talks
…
continue reading
In season 4, episode 9 of Targeted Talks, Kerry Reynolds, MD of Massachusetts General Hospital discusses the occurrence of myocarditis in patients with cancer treated with immune checkpoint inhibitors.Από τον Targeted Talks
…
continue reading
An interview with Ruchi Garg, MD of City of Hope.Από τον Targeted Talks
…
continue reading
Από τον Targeted Talks
…
continue reading
An interview with Warren Swegal, MD.Από τον Targeted Talks
…
continue reading
An interview with Alice P. Chen, MD of the National Cancer Institute.Από τον Targeted Talks
…
continue reading
Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.Από τον Targeted Talks
…
continue reading
In season 4, episode 3 of Targeted Talks, Pedro Barata, MD, MSc, discusses the present and future of prostate cancer precision medicine.Από τον Targeted Talks
…
continue reading
A talk with Sara A. Hurvitz, MD about advances in the HER2-positive breast cancer space.Από τον Targeted Talks
…
continue reading
In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.Από τον Targeted Talks
…
continue reading
In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.Από τον Targeted Talks
…
continue reading
In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.Από τον Targeted Talks
…
continue reading
In season 3, episode 8 of Targeted Talks, Christie J. Hilton, DO, discusses treating first- and second-line HER2-positive breast cancer.Από τον Targeted Talks
…
continue reading
In season 3, episode 7 of Targeted Talks, John Nakayama, MD, a gynecologic oncologist at Allegheny Health Network, discusses updates in the endometrial cancer treatment landscape.Από τον Targeted Talks
…
continue reading
Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.Από τον Targeted Talks
…
continue reading
In season 3, episode 5 of Targeted Talks, Thomas Habermann, MD, discusses the latest advances in the treatment of diffuse large B-cell lymphoma.Από τον Targeted Talks
…
continue reading
In season 3, episode 4 of Targeted Talks, Alexey Danilov, MD, PhD, discusses the shift toward utilizing cellular therapy to treat high-risk patients with chronic lymphocytic leukemia.Από τον Targeted Talks
…
continue reading
In season 3, episode 3 of Targeted Talks, William J. Gradishar, MD, discusses the latest version of the NCCN Clinical Practice Guidelines for managing early-stage breast cancer.Από τον Targeted Talks
…
continue reading
Mark Agulnik, MD, City of Hope Comprehensive Cancer Center joins Targeted Oncology for a discussion about the sarcoma treatment landscape and pending innovations under investigation in clinical trials.Από τον Targeted Talks
…
continue reading
In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.Από τον Targeted Talks
…
continue reading
Sandra P. D'Angelo, MD and Katherine Poruk, MDΑπό τον Targeted Talks
…
continue reading
In season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.Από τον Targeted Talks
…
continue reading
In season 2, episode 8 of “Targeted Talks,” Thomas Hutson, DO, PharmD, and Rana R. McKay, MD, of UC San Diego Health, discussed the renal cell carcinoma paradigm and challenges to overcome in the future.Από τον Targeted Talks
…
continue reading